Running Title: Role of Cbl mutations in myeloid transformation

作者: Lara Tickenbrock , Ivan Dikic , Steffen Koschmieder , Bülent Sargin , Benjamin August

DOI:

关键词: Signal transductionGeneticsReceptor tyrosine kinaseUbiquitinMyeloidPhosphorylationCell biologyTyrosineBiologyInternalizationMyeloid leukemia

摘要: Abstract In acute myeloid leukemia (AML), mutational activation of the receptor tyrosine kinase (RTK) Flt3 is frequently involved in leukemic transformation. However, little known about a possible role highly expressed wild-type AML. The proto-oncogene c-Cbl an important regulator RTK signaling, acting through its ubiquitin ligase activity and as platform for several signaling adaptor molecules. Here, we analyzed signal transduction C-Cbl physically interacted with was phosphorylated presence Flt3-ligand (FL). Overexpression dominant negative form (Cbl-70Z) inhibited FL-induced ubiquitylation internalization, indicating involvement signaling. DNA sequencing AML bone marrow revealed case point mutation (Cbl-R420Q). Cbl-R420Q internalization ubiquitylation. Co-expression or Cbl-70Z induced cytokine-independent growth survival 32Dcl3 cells absence FL. Also, mutant Cbl proteins altered amplitude duration Flt3-dependent events. Our results indicate modulation. data suggest novel mechanism transformation by inactivation regulators. From bloodjournal.hematologylibrary.org guest on June 6, 2013. For personal use only.

参考文章(59)
Torsten Haferlach, Axel Heyll, Christa Fonatsch, Maria-Cristina Sauerland, Achim Heinecke, Wolfgang Hiddemann, Bernhard Wörmann, Dieter Hossfeld, Helmut Löffler, Detlef Haase, Claudia Schoch, Georg Maschmeyer, Wolf-Dieter Ludwig, Eva Lengfelder, Winfried Gassmann, Carlo Aul, Thomas Büchner, Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Blood. ,vol. 93, pp. 4116- 4124 ,(1999) , 10.1182/BLOOD.V93.12.4116
Maria F Brizzi, Patrizia Dentelli, Luisa Lanfrancone, Arturo Rosso, Pier Giuseppe Pelicci, Luigi Pegoraro, None, Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and TPO-mediated myeloid cell proliferation. Oncogene. ,vol. 13, pp. 2067- 2076 ,(1996)
C.E. Andoniou, C.B. Thien, W.Y. Langdon, Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. The EMBO Journal. ,vol. 13, pp. 4515- 4523 ,(1994) , 10.1002/J.1460-2075.1994.TB06773.X
Masao Mizuki, Regina Fenski, Hartmut Halfter, Itaru Matsumura, Rainer Schmidt, Carsten Müller, Wolfram Grüning, Karsten Kratz-Albers, Susanne Serve, Claudia Steur, Thomas Büchner, Joachim Kienast, Yuzuru Kanakura, Wolfgang E. Berdel, Hubert Serve, Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. Blood. ,vol. 96, pp. 3907- 3914 ,(2000) , 10.1182/BLOOD.V96.12.3907
Christine B. F. Thien, Wallace Y. Langdon, Cbl: many adaptations to regulate protein tyrosine kinases Nature Reviews Molecular Cell Biology. ,vol. 2, pp. 294- 307 ,(2001) , 10.1038/35067100
Wuyi Meng, Sansana Sawasdikosol, Steven J. Burakoff, Michael J. Eck, Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase Nature. ,vol. 398, pp. 84- 90 ,(1999) , 10.1038/18050
Peter Blume-Jensen, Tony Hunter, Oncogenic kinase signalling. Nature. ,vol. 411, pp. 355- 365 ,(2001) , 10.1038/35077225
Rebecca D. Chernock, Rama P. Cherla, Ramesh K. Ganju, SHP2 and cbl participate in α-chemokine receptor CXCR4–mediated signaling pathways Blood. ,vol. 97, pp. 608- 615 ,(2001) , 10.1182/BLOOD.V97.3.608
Annalisa Petrelli, Giorgio F. Gilestro, Stefania Lanzardo, Paolo M. Comoglio, Nicola Migone, Silvia Giordano, The endophilin–CIN85–Cbl complex mediates ligand-dependent downregulation of c-Met Nature. ,vol. 416, pp. 187- 190 ,(2002) , 10.1038/416187A
Kaisa Haglund, Sara Sigismund, Simona Polo, Iwona Szymkiewicz, Pier Paolo Di Fiore, Ivan Dikic, Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation Nature Cell Biology. ,vol. 5, pp. 461- 466 ,(2003) , 10.1038/NCB983